Outcomes in Patients With Transcatheter Aortic Valve Replacement and Left Main Stenting
The TAVR-LM Registry
Tarun Chakravarty, Rahul Sharma, Yigal Abramowitz, Samir Kapadia, Azeem Latib, Hasan Jilaihawi, Kanhaiya Lal Poddar, Gennaro Giustino, Henrique B. Ribeiro, Didier Tchetche, Benoit Monteil, Luca Testa, Giuseppe Tarantini, Michela Facchin, Thierry Lefèvre, Brian R. Lindman, Babak Hariri, Jigar Patel, Nobuyuki Takahashi, George Matar, James Mirocha, Wen Cheng, Murat E. Tuzcu, Horst Sievert, Josep Rodés-Cabau, Antonio Colombo, Ariel Finkelstein, Jean Fajadet and Raj R. Makkar
Transcatheter Aortic Valve Replacement and Left Main Coronary Artery Stenting
(A) Concept and technical aspects. (B) One-year mortality after transcatheter aortic valve replacement (TAVR) plus left main coronary artery (LM) percutaneous coronary intervention (PCI) versus matched control subjects. There was no difference in 1-year mortality in patients undergoing TAVR plus LM PCI compared with matched control subjects.